Literature DB >> 1541672

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

A Vaag1, J E Henriksen, H Beck-Nielsen.   

Abstract

Insulin resistance in non-insulin-dependent diabetes is associated with a defective insulin activation of the enzyme glycogen synthase in skeletal muscles. To investigate whether this may be a primary defect, we studied 20 young (25 +/- 1 yr) Caucasian first-degree relatives (children) of patients with non-insulin-dependent diabetes, and 20 matched controls without a family history of diabetes. Relatives and controls had a normal oral glucose tolerance, and were studied by means of the euglycemic hyperinsulinemic clamp technique, which included performance of indirect calorimetry and muscle biopsies. Insulin-stimulated glucose disposal was decreased in the relatives (9.2 +/- 0.6 vs 11.5 +/- 0.5 mg/kg fat-free mass per (FFM) min, P less than 0.02), and was due to a decreased rate of insulin-stimulated nonoxidative glucose metabolism (5.0 +/- 0.5 vs 7.5 +/- 0.4 mg/kg fat-free mass per min, P less than 0.001). The insulin-stimulated, fractional glycogen synthase activity (0.1/10 mmol liter glucose-6-phosphate) was decreased in the relatives (46.9 +/- 2.3 vs 56.4 +/- 3.2%, P less than 0.01), and there was a significant correlation between insulin-stimulated, fractional glycogen synthase activity and nonoxidative glucose metabolism in relatives (r = 0.76, P less than 0.001) and controls (r = 0.63, P less than 0.01). Furthermore, the insulin-stimulated increase in muscle glycogen content over basal values was lower in the relatives (13 +/- 25 vs 46 +/- 9 mmol/kg dry wt, P = 0.05). We conclude that the defect in insulin activation of muscle glycogen synthase may be a primary, possibly genetically determined, defect that contributes to the development of non-insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541672      PMCID: PMC442922          DOI: 10.1172/JCI115656

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle.

Authors:  P Dent; A Lavoinne; S Nakielny; F B Caudwell; P Watt; P Cohen
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

Review 2.  Assessment of insulin sensitivity in vivo: a critical review.

Authors:  R N Bergman; I D Hope; Y J Yang; R M Watanabe; M A Meador; J H Youn; M Ader
Journal:  Diabetes Metab Rev       Date:  1989-08

3.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

4.  Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.

Authors:  A Golay; R A DeFronzo; E Ferrannini; D C Simonson; D Thorin; K Acheson; D Thiébaud; B Curchod; E Jéquier; J P Felber
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

5.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

Authors:  J H Warram; B C Martin; A S Krolewski; J S Soeldner; C R Kahn
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

6.  Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle.

Authors:  Y Kida; A Esposito-Del Puente; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

7.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Authors:  J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

8.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

Authors:  R DeFronzo; D Deibert; R Hendler; P Felig; V Soman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; P Skött; P Damsbo; M A Gall; E A Richter; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

Authors:  L J Mandarino; K S Wright; L S Verity; J Nichols; J M Bell; O G Kolterman; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more
  71 in total

1.  Skeletal muscle insulin resistance: is it important for the pathogenesis of type 2 diabetes after all?

Authors:  H A Koistinen; J R Zierath
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 2.  Insulin signaling defects in type 2 diabetes.

Authors:  Ying Leng; Håkan K R Karlsson; Juleen R Zierath
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Muscle-specific Pten deletion protects against insulin resistance and diabetes.

Authors:  Nadeeja Wijesekara; Daniel Konrad; Mohamed Eweida; Craig Jefferies; Nicole Liadis; Adria Giacca; Mike Crackower; Akira Suzuki; Tak W Mak; C Ronald Kahn; Amira Klip; Minna Woo
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Genome-wide linkage scans for prediabetes phenotypes in response to 20 weeks of endurance exercise training in non-diabetic whites and blacks: the HERITAGE Family Study.

Authors:  P An; M Teran-Garcia; T Rice; T Rankinen; S J Weisnagel; R N Bergman; R C Boston; S Mandel; D Stefanovski; A S Leon; J S Skinner; D C Rao; C Bouchard
Journal:  Diabetologia       Date:  2005-05-03       Impact factor: 10.122

5.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Plasma cytokine levels in young and elderly twins: genes versus environment and relation to in vivo insulin action.

Authors:  L Grunnet; P Poulsen; B Klarlund Pedersen; T Mandrup-Poulsen; A Vaag
Journal:  Diabetologia       Date:  2005-12-23       Impact factor: 10.122

7.  The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans.

Authors:  Vicencia Sales; Mary-Elizabeth Patti
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-09

8.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.